Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Eritrea
Eritrea: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 89.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Eritrea, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Eritrea recorded 89.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 4.7% on the previous year and up 1.1% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Eritrea peaked at 89.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Eritrea 74th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Eritrea, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 88.0% | — |
| 2016 | 88.0% | +0.0% |
| 2017 | 88.0% | +0.0% |
| 2018 | 85.0% | -3.4% |
| 2019 | 85.0% | +0.0% |
| 2020 | 85.0% | +0.0% |
| 2021 | 85.0% | +0.0% |
| 2022 | 85.0% | +0.0% |
| 2023 | 85.0% | +0.0% |
| 2024 | 85.0% | +0.0% |
| 2025 | 89.0% | +4.7% |
Eritrea compared with similar countries
- Eritrea's 89.0% is above the median for low income countries, which is 60.0%, 1.5× the median. (25 countries reporting)
- Eritrea's 89.0% is above the median for Sub-Saharan Africa, which is 66.0%, 1.3× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 43.4% | 0.0% | 88.0% | 10 |
| 2020s | 85.7% | 85.0% | 89.0% | 6 |
Countries ranked near Eritrea
More health data for Eritrea
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.2 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 425 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2011)
- Population ages 00-04, female, per capita 0.0652 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.73 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2011)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Eritrea?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Eritrea was 89.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Eritrea?
- The highest recorded value was 89.0% in 2025.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Eritrea?
- The lowest recorded value was 0.0% in 2000.
- How does Eritrea rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Eritrea ranks 74th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Eritrea?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is volatile.
- Where does this Eritrea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).